Portfolio Companies News
February 17, 2017Publishing of Nexstim Plc 2016 Full...
17 February 2017 Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, will announce its full year results for the year ended 31 December 2016 in the morning of Monday 28 February 2017. A conference call for analysts... read more
February 16, 2017Targovax ASA: Fourth quarter and fu...
Oslo, Norway, 16 February 2017 - Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its fourth quarter and full year 2016 results. A meeting for investors, analysts and press will... read more
February 13, 2017Onxeo receives USPTO Notice of Allo...
New patent expands Onxeo’s intellectual property to a large family of compounds related to AsiDNA™ Paris (France), February 13, 2017 – 18:00 CET – Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in the development of innovativ... read more
February 8, 2017Information on ReLive Trial Design ...
Paris (France), February 8, 2017 – 8.30 am CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, wishes to clarify information rega... read more
February 8, 2017Oncopeptides AB (publ) announces a ...
February 8, 2017 Press releases NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN.Oncopeptides AB (publ) (”Oncopeptides” or the ”Company”) has, together with HealthCap and Indust... read more
February 06, 2017Q4 2016 General Market Overview